ClassID:

96740

C07K7/08 - page 5 - CPC Classification

Classification description:

Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 12 to 20 amino acids

Recent Application in this class:
#1201
20200361992
2020-11-19

Conjugated hepcidin mimetics

#1202
20200361991
2020-11-19

Compounds for selective disruption of protein-protein interactions

#1203
20200361990
2020-11-19

Polypeptide having analgesic activity and use thereof

#1204
20200355693
2020-11-12

Marker for predicting the sensitivity to PI3K inhibitors

#1205
20200354588
2020-11-12

ANTI-FOULING PAINTS AND COATINGS

#1206
20200354407
2020-11-12

Peptide inhibitors of insulin-degrading enzyme

#1207
20200354405
2020-11-12

METHOD FOR ACTIVATING HELPER T CELL

#1208
20200353032
2020-11-12

LYTIC-PEPTIDE-HER2/NEU (HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2) LIGAND CONJUGATES AND METHODS OF USE

#1209
20200352899
2020-11-12

Bcl-w polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neuropathy and hearing loss

#1210
20200352839
2020-11-12

Composition for prevention or treatment of hair loss

#1211
20200347111
2020-11-05

N-terminal fusion partner for producing recombinant polypeptide, and method for producing recombinant polypeptide using same

#1212
20200347106
2020-11-05

COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF

#1213
20200347096
2020-11-05

Cyclic peptide and a medicament, external preparation and cosmetic comprising said cyclic peptide

#1214
20200347095
2020-11-05

Methods for treating cancer

#1215
20200345777
2020-11-05

Immunotherapy against neuronal and brain tumors

#1216
20200340984
2020-10-29

METHODS OF QUANTIFYING CFTR PROTEIN EXPRESSION

#1217
20200339630
2020-10-29

Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers

#1218
20200339629
2020-10-29

THERAPEUTIC CONSTRUCTS COMPRISING CMET BINDING PEPTIDES

#1219
20200338202
2020-10-29

Short TAT oligomers for drug delivery

#1220
20200331967
2020-10-22

Peptide for suppressing osteoclast differentiation and use thereof

#1221
20200331966
2020-10-22

Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof

#1222
20200330605
2020-10-22

Anti-tumour immune responses to modified self-epitopes

#1223
20200325207
2020-10-15

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

#1224
20200325194
2020-10-15

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#1225
20200325176
2020-10-15

Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis

#1226
20200325175
2020-10-15

CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS

#1227
20200325173
2020-10-15

Drug Delivery Enhancement Agents

#1228
20200323968
2020-10-15

Method of treating with a peptide

#1229
20200323967
2020-10-15

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

#1230
20200317736
2020-10-08

Stabilized polypeptides and uses thereof

#1231
20200317734
2020-10-08

Amyloid-beta-binding peptides and the use thereof for the treatment and diagnosis of Alzheimer's disease

#1232
20200317733
2020-10-08

FOXP3-binding peptides and uses thereof

#1233
20200316182
2020-10-08

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

#1234
20200316127
2020-10-08

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#1235
20200316126
2020-10-08

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#1236
20200316125
2020-10-08

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#1237
20200315941
2020-10-08

Method of facilitating the bindings between keratinocytes

#1238
20200309778
2020-10-01

Thioredoxin 1 epitope, encoding nucleic acid and methods of binding a monoclonal antibody

#1239
20200308236
2020-10-01

Stapled intracellular-targeting antimicrobial peptides to treat infection

#1240
20200308231
2020-10-01

Solution-phase affinity selection of inhibitors from combinatorial peptide libraries

#1241
20200308229
2020-10-01

α4α7 peptide monomer and dimer antagonists

#1242
20200308228
2020-10-01

PEPTIDE INHIBITORS OF HCV NS3/4A PROTEASE COMPRISING NON-PROTEINOGENIC AMINO RESIDUES

#1243
20200308227
2020-10-01

Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

#1244
20200308226
2020-10-01

Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

#1245
20200308225
2020-10-01

Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

#1246
20200308224
2020-10-01

DEPDC1-derived peptide and vaccine containing same

#1247
20200299627
2020-09-24

Crosslinked hydrogel compositions for regulating states of encapsulated cancer cells

#1248
20200299348
2020-09-24

Cell-permeable bone morphogenetic protein (CPBMP) recombinant protein and use thereof

#1249
20200297760
2020-09-24

COMPOSITIONS AND METHODS FOR REDUCING IMMUNE RESPONSES AGAINST CHIMERIC ANTIGEN RECEPTORS

#1250
20200292534
2020-09-17

Activation of bioluminescene by structural complementation

#1251
20200291084
2020-09-17

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#1252
20200291068
2020-09-17

Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof

#1253
20200291067
2020-09-17

IL-2Rgamma binding compounds

#1254
20200291066
2020-09-17

IL-2RBETA binding compounds

#1255
20200289677
2020-09-17

Activatable membrane-interacting peptides and methods of use

#1256
20200289657
2020-09-17

Bicyclic peptide ligands specific for MT1-MMP

#1257
20200289631
2020-09-17

Method of treating with a peptide

#1258
20200284799
2020-09-10

RAPID TEST FOR CELLULAR FIBRONECTIN

#1259
20200283481
2020-09-10

Bifunctional peptide having capability to reduce inflammation and capability to facilitate differentiation of stem cells into chondrocytes and use thereof

#1260
20200283480
2020-09-10

AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS

#1261
20200283479
2020-09-10

Treatments for Gastrointestinal Disorders

#1262
20200277588
2020-09-03

Engineered cascade components and cascade complexes

#1263
20200276322
2020-09-03

Peptide compositions and methods of use thereof

#1264
20200276130
2020-09-03

Therapeutic cationic peptides and unimolecular nanoparticles for efficient delivery thereof

#1265
20200270310
2020-08-27

MAFG AS A POTENTIAL THERAPEUTIC TARGET TO RESTORE CHEMOSENSITIVITY IN PLATINUM-RESISTANT CANCER CELLS

#1266
20200270309
2020-08-27

MALEIMIDE GROUP-MODIFIED ANGIOGENESIS INHIBITOR HM-1 AND USE THEREOF

#1267
20200270308
2020-08-27

Cancer treatment drug

#1268
20200270307
2020-08-27

Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same

#1269
20200268862
2020-08-27

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml)

#1270
20200255889
2020-08-13

SEROLOGICAL ASSAY FOR DETECTION OF EXPOSURE TO AND INFECTION BY TICK-BORNE PATHOGENS

#1271
20200255508
2020-08-13

Therapeutic DLL4 Binding Proteins

#1272
20200255483
2020-08-13

Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin

#1273
20200255474
2020-08-13

Peptide derivative and pharmaceutical composition containing same

#1274
20200254109
2020-08-13

Peptide oligonucleotide conjugates

#1275
20200254078
2020-08-13

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)

#1276
20200254076
2020-08-13

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy

#1277
20200247858
2020-08-06

Agents modulating beta-catenin functions and methods thereof

#1278
20200247850
2020-08-06

Polypeptides for the treatment of diseases

#1279
20200247849
2020-08-06

Peptide agonists and antagonists of TLR4 activation

#1280
20200247848
2020-08-06

Alpha conotoxin peptides

#1281
20200240989
2020-07-30

CHLAMYDIA SUIS DIAGNOSIS

#1282
20200240982
2020-07-30

Use of Specific Covalent Bonding for Oriented Immobilization of Recombinant Antibody Fragments

#1283
20200239632
2020-07-30

Peptoid polymers and methods of use

#1284
20200239533
2020-07-30

Ras inhibitory peptides and uses thereof

#1285
20200239523
2020-07-30

NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS

#1286
20200239522
2020-07-30

Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic delivery

#1287
20200239521
2020-07-30

Noxa-derived, cell death-inducing peptide eMTD

#1288
20200237925
2020-07-30

Polypeptide eye absorption enhancer and use thereof

#1289
20200237924
2020-07-30

Conotoxin peptide analogs and uses for the treatment of pain and inflammatory conditions

#1290
20200231637
2020-07-23

Antimicrobial adhesive protein, antimicrobial nanoparticle, antimicrobial composition comprising same nanoparticle, and preparation method for same composition

#1291
20200231628
2020-07-23

Antimicrobial peptide derived from myxinidin peptide and uses thereof

#1292
20200230201
2020-07-23

Peptide inhibitors of twist

#1293
20200230200
2020-07-23

Antimicrobial peptides and methods of using the same

#1294
20200223888
2020-07-16

DPEP-1 binding agents and methods of use

#1295
20200222548
2020-07-16

Synthetic bioconjugates

#1296
20200222541
2020-07-16

LINACLOTIDE COMPOSITIONS

#1297
20200222496
2020-07-16

TISSUE OCCLUDING AGENT

#1298
20200216558
2020-07-09

Monoclonal antibodies targeting glypican-2 (GPC2) and use thereof

#1299
20200216517
2020-07-09

Integrin Antagonists

#1300
20200216504
2020-07-09

Peptides for treatment and prevention of hyperglycaemia

#1301
20200216498
2020-07-09

Immunomodulators

#1302
20200216497
2020-07-09

Antimicrobial peptide derived from Hp1404 peptide and uses thereof

#1303
20200215191
2020-07-09

Methods and compositions related to inhibition of viral entry

#1304
20200207873
2020-07-02

Antibodies and peptides to treat HCMV related diseases

#1305
20200207822
2020-07-02

PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES

#1306
20200206330
2020-07-02

PARTNER OF SLD FIVE 1 (PSF1)-DERIVED PEPTIDE

#1307
20200206308
2020-07-02

Suppression of allergic lung inflammation and hyperreactivity

#1308
20200206301
2020-07-02

JNK Inhibitor Molecules For Treatment Of Various Diseases

#1309
20200199195
2020-06-25

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

#1310
20200199179
2020-06-25

Peptide library and use thereof

#1311
20200197902
2020-06-25

Supramolecular filamentous assemblies for protein purification

#1312
20200190516
2020-06-18

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPY

#1313
20200190220
2020-06-18

Circular tandem repeat proteins

#1314
20200190159
2020-06-18

Use of tetranectin and peptide agonists to treat inflammatory diseases

#1315
20200190155
2020-06-18

NEMO coiled coil mimics and methods of using same

#1316
20200190145
2020-06-18

Antimicrobial peptides and their use

#1317
20200190144
2020-06-18

Self-assembling peptides comprising non-ionic polar amino acids for anti-adhesion

#1318
20200181201
2020-06-11

Targeting α2δ-1-bound glutamate receptors for treating diseases and disorders

#1319
20200181199
2020-06-11

Compstatin analogs with increased solubility and improved pharmacokinetic properties

#1320
20200181198
2020-06-11

Peptides for binding epidermal growth factor

#1321
20200181197
2020-06-11

Therapeutic peptides

#1322
20200181196
2020-06-11

Site-specific radioisotope-labeled antibody using IgG-binding peptide

#1323
20200178517
2020-06-11

Recrystallization inhibitor

#1324
20200172913
2020-06-04

PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF VIRUS

#1325
20200172911
2020-06-04

USP30 INHIBITORS AND METHODS OF USE

#1326
20200172574
2020-06-04

INHIBITION OF CARDIAC FIBROSIS IN MYOCARDIAL INFARCTION

#1327
20200171161
2020-06-04

Bicyclic peptide ligands specific for MT1-MMP

#1328
20200166460
2020-05-28

Reactive peptide labeling

#1329
20200165299
2020-05-28

Compositions and methods for treating pulmonary hypertension

#1330
20200165298
2020-05-28

Inhibition of pulmonary fibrosis with nutlin-3a and peptides

#1331
20200164093
2020-05-28

Molecular imaging of cancer cells in vivo

#1332
20200157191
2020-05-21

MVA-gH/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereof

#1333
20200157165
2020-05-21

PEPTIDES HAVING OSTEOBLAST GROWTH-PROMOTING ACTIVITY AND USE THEREOF

#1334
20200157147
2020-05-21

Polypeptide derived from CAP1 and pharmaceutical composition comprising same as effective ingredient

#1335
20200155603
2020-05-21

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#1336
20200155596
2020-05-21

KOC1-derived peptide and vaccine including same

#1337
20200150129
2020-05-14

Lysine monomethylated derivative and corresponding antibody and use thereof

#1338
20200140504
2020-05-07

Peptide for toll-like receptor (TLR) inhibition and pharmaceutical composition comprising same

#1339
20200138979
2020-05-07

Fibroblast growth factor receptor 2-specific peptide reagents and methods

#1340
20200138924
2020-05-07

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

#1341
20200131234
2020-04-30

Micropeptides and use of same for modulating gene expression

#1342
20200131228
2020-04-30

Bicyclic peptide ligands and uses thereof

#1343
20200131227
2020-04-30

POLYPEPTIDE WITH TUMOUR BINDING ACTIVITY

#1344
20200123558
2020-04-23

Peptides and methods and uses thereof for modulating anaphase promoting complex (APC) activity

#1345
20200123247
2020-04-23

MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)

#1346
20200123208
2020-04-23

PEPTIDES AND NEMATICIDAL COMPOSITIONS

#1347
20200123202
2020-04-23

Modulation of complement activity

#1348
20200123201
2020-04-23

Peptide compositions and methods of use

#1349
20200121771
2020-04-23

Telomerase polypeptide vaccine for treating cancer

#1350
20200115418
2020-04-16

Anti-HIV peptides

#1351
20200115415
2020-04-16

Antiplasmodial compounds

#1352
20200115414
2020-04-16

Nicotinic acetylcholine receptor peptide antagonist conotoxin compositions and related methods

#1353
20200115413
2020-04-16

Method of sensitizing cancer cells to anti-cancer treatment

#1354
20200113968
2020-04-16

AGONISTS OF GUANYLATE CYCLASE USEFUL FOR DOWNREGULATION OF PRO-INFLAMMATORY CYTOKINES

#1355
20200109172
2020-04-09

Compositions for expanding regulatory T cells (Treg) populations, and treating and ameliorating autoimmune diseases and conditions

#1356
20200109171
2020-04-09

Anti-microbial peptides

#1357
20200109170
2020-04-09

Short synthetic peptide and uses thereof

#1358
20200103409
2020-04-02

INHIBITORS OF PROTEINS SPECIFIC FOR THE SECRETOME OF A CHONDROCYTE FOR USE IN THE TREATMENT OF BREAST CANCER METASTASIS

#1359
20200102359
2020-04-02

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#1360
20200102350
2020-04-02

Peptide that regulates fat metabolism and method for regulating fat metabolism

#1361
20200102349
2020-04-02

PEPTIDE REAGENTS AND METHODS FOR DETECTION AND TARGETING OF DYSPLASIA, EARLY CANCER AND CANCER

#1362
20200101169
2020-04-02

Antigen-specific tolerance and compositions for induction of same

#1363
20200095293
2020-03-26

Peptides and compositions for prevention of cell adhesion and methods of using same

#1364
20200095284
2020-03-26

MODULATION OF THE IMMUNE RESPONSE

#1365
20200095283
2020-03-26

Agrobacterium derived cell penetrating peptides as nanocarriers

#1366
20200095282
2020-03-26

Peptides capable of reactivating p53 mutants

#1367
20200095281
2020-03-26

Melanocortin Receptor Ligands

#1368
20200093906
2020-03-26

Peptides and combination of peptides for use in immunotherapy against various cancers

#1369
20200093905
2020-03-26

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)

#1370
20200093902
2020-03-26

Vista antagonist and methods of use

#1371
20200093888
2020-03-26

Labyrinthopeptins as anti-viral agents

#1372
20200093849
2020-03-26

URLC10-DERIVED PEPTIDE AND VACCINE CONTAINING SAME

#1373
20200087349
2020-03-19

BROAD-SPECTRUM ANTI-INFECTIVE PEPTIDES

#1374
20200087346
2020-03-19

Prostate-specific membrane antigen (PSMA) targeting peptides

#1375
20200085930
2020-03-19

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS

#1376
20200085927
2020-03-19

Compound comprising an autoantigenic peptide and a carrier with a MHC binding motif

#1377
20200081004
2020-03-12

Antibodies binding to TLR2/TLR4-interacting immunologically active polypeptide

#1378
20200078439
2020-03-12

Powerful MHC-class II peptides derived from survivin

#1379
20200071544
2020-03-05

Conotoxin peptides for use in biofouling deterrence

#1380
20200071407
2020-03-05

Inhibitors of prototypic galectin dimerization and uses thereof

#1381
20200071365
2020-03-05

Mycobacteria tuberculosis chaperonin 60.1 peptides and uses thereof

#1382
20200071358
2020-03-05

Biocidal peptide and preparation based thereon

#1383
20200071357
2020-03-05

ANTIMICROBIAL PEPTIDES

#1384
20200071355
2020-03-05

THERAPEUTIC PEPTIDES

#1385
20200069551
2020-03-05

Composition for improving hair health

#1386
20200064352
2020-02-27

Specific GNAI:GIV interaction screening assays, methods and compositions

#1387
20200062809
2020-02-27

METHOD FOR SEPARATING AND PURIFYING MUSSEL ADHESIVE PROTEIN

#1388
20200062808
2020-02-27

Peptides and compositions for prevention of cell adhesion and methods of using same

#1389
20200062805
2020-02-27

Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway

#1390
20200061170
2020-02-27

Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers

#1391
20200055918
2020-02-20

NOVEL MINOR HISTOCOMPATIBILITY ANTIGENS AND USES THEREOF

#1392
20200055899
2020-02-20

PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS

#1393
20200055898
2020-02-20

Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers

#1394
20200054729
2020-02-20

Method of treating with a peptide

#1395
20200054727
2020-02-20

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#1396
20200048622
2020-02-13

Engineered cascade components and cascade complexes

#1397
20200048309
2020-02-13

Multivalent ligand-lipid constructs

#1398
20200048308
2020-02-13

INFLUENZA VIRUS NEUTRALIZING COMPOUNDS

#1399
20200048303
2020-02-13

Antimicrobial peptides and methods of making and using same

#1400
20200046844
2020-02-13

Peptide-polynucleotide complex for polynucleotide transfection

#1401
20200046819
2020-02-13

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

#1402
20200045956
2020-02-13

POLYPEPTIDE SPERM STABILISER FOR SEMEN USED IN ARTIFICIAL INSEMINATION

#1403
20200040038
2020-02-06

Process of Preparing Guanylate Cyclase C Agonists

#1404
20200040036
2020-02-06

IL-2Rγ binding compounds

#1405
20200040035
2020-02-06

Antimicrobial peptide having synergistic antibacterial effect with antibiotics on multidrug resistant bacteria, and use thereof

#1406
20200040034
2020-02-06

IL-2RBeta binding compounds

#1407
20200040033
2020-02-06

Epitope tag and method for detection and/or purification of tagged polypeptides

#1408
20200038523
2020-02-06

PSMA-specific binding proteins

#1409
20200038516
2020-02-06

Dosing regimens and related compositions and methods

#1410
20200038473
2020-02-06

Peptides that block leukocyte recruitment and methods of use

#1411
20200031905
2020-01-30

Human APOB100 epitopes, methods and uses for modulating inflammatory responses, and treating adverse cardiovascular events, disease and atherosclerosis

#1412
20200031884
2020-01-30

MICROPEPTIDES AND USE OF SAME FOR MODULATING GENE EXPRESSION

#1413
20200031870
2020-01-30

Immunotherapy against several tumors, such as lung cancer, including NSCLC

#1414
20200031869
2020-01-30

Immunotherapy against several tumors, such as lung cancer, including NSCLC

#1415
20200031868
2020-01-30

Immunotherapy against several tumors including lung cancer

#1416
20200031867
2020-01-30

Immunotherapy against several tumors including lung cancer

#1417
20200031866
2020-01-30

PEPTIDE INHIBITORS OF SODIUM CHANNELS

#1418
20200023034
2020-01-23

FC receptor (FcRn) binding peptides and uses thereof

#1419
20200018762
2020-01-16

PHOSPHORYLATION OF HISTONES AND USES THEREOF

#1420
20200017563
2020-01-16

Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segment

#1421
20200017562
2020-01-16

Methods and compositions for treating neurodegenerative disorders and Alzheimer's Disease and improving normal memory

#1422
20200017551
2020-01-16

Immunotherapy against several tumors, such as lung cancer, including NSCLC

#1423
20200017550
2020-01-16

Peptides and methods of using same

#1424
20200017549
2020-01-16

NOVEL a4B7 PEPTIDE ANTAGONISTS

#1425
20200010529
2020-01-09

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

#1426
20200010509
2020-01-09

Agonist of spexin-based galanin type 2 receptor and use thereof

#1427
20200010508
2020-01-09

Glypican-3 peptide reagents and methods

#1428
20200010507
2020-01-09

Inhibition of the aggregation of transthyretin by specific binding of peptides to aggregation-driving segments

#1429
20200010506
2020-01-09

Antibacterial cyclic lipopeptides

#1430
20200010502
2020-01-09

SYNTHESIS OF MULTIPHOSPHORYLATED PEPTIDES

#1431
20200009063
2020-01-09

FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE

#1432
20200002381
2020-01-02

Methods of reducing neuronal injury or toxicity in epilepsy, Alzheimer's disease or Parkinson's disease using a scorpion venom heat-resistant synthetic peptide (SVHRSP)

#1433
20200002380
2020-01-02

Modulation of complement activity

#1434
20200002379
2020-01-02

AMYLOID-BETA-BINDING PEPTIDES AND THE USE THEREOF FOR THE TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE

#1435
20200002376
2020-01-02

Melanocortin 1 receptor ligands and methods of use

#1436
20200002374
2020-01-02

Process for the preparation of a dodecapeptide

#1437
20200000902
2020-01-02

Peptides and combination of peptides for use in immunotherapy against various cancers

#1438
20200000850
2020-01-02

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#1439
20200000849
2020-01-02

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#1440
20200000722
2020-01-02

Synthetic polypeptides and uses thereof

#1441
20190389931
2019-12-26

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

#1442
20190389907
2019-12-26

PEPTIDE LIGANDS FOR BINDING TO MT1-MMP

#1443
20190389906
2019-12-26

Bicyclic peptide ligands specific for Nectin-4

#1444
20190387748
2019-12-26

COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE

#1445
20190383834
2019-12-19

Conformational mimotopes for detecting specific antibodies

#1446
20190383813
2019-12-19

Methods for detecting peptide/MHC/TCR binding

#1447
20190383812
2019-12-19

Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom

#1448
20190382738
2019-12-19

Peptide based inhibitors of Raf kinase protein dimerization and kinase activity

#1449
20190382479
2019-12-19

Erythrocyte-binding therapeutics

#1450
20190382468
2019-12-19

Methods and compositions for the treatment of cancer

#1451
20190382448
2019-12-19

pH-sensitive cyclic peptides

#1452
20190382444
2019-12-19

Zinc-binder based EBNA1-specific compounds

#1453
20190381103
2019-12-19

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#1454
20190375810
2019-12-12

Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species

#1455
20190375791
2019-12-12

NEW D-CONFIGURED CATESLYTIN PEPTIDE

#1456
20190375790
2019-12-12

Multi-target peptide molecules of opioid and neuropeptide FF receptor, preparation for molecules, and applications thereof

#1457
20190375789
2019-12-12

IMMUNE SYSTEM MODULATORS

#1458
20190375788
2019-12-12

METHODS AND COMPOSITIONS FOR TREATMENT OF CARTILAGE AND DISC TISSUE PATHOLOGIES

#1459
20190367929
2019-12-05

CTLA4/PD1 targeted/immunomodulatory fusion proteins

#1460
20190367560
2019-12-05

Solid-phase support comprising IgG-binding peptide, and method for separating IgG

#1461
20190367559
2019-12-05

Vasoactive polypeptides for smooth muscle relaxation

#1462
20190367558
2019-12-05

ANTIBODY/DRUG CONJUGATES AND METHODS OF USE

#1463
20190365883
2019-12-05

Influenza Peptides and Compositions

#1464
20190359681
2019-11-28

NOVEL MINOR HISTOCOMPATIBILITY ANTIGENS AND USES THEREOF

#1465
20190359669
2019-11-28

Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof

#1466
20190359653
2019-11-28

SELECTIVE PEPTIDE INHIBITORS OF FRIZZLED

#1467
20190358144
2019-11-28

Compositions comprising peptide WKDEAGKPLVK

#1468
20190352348
2019-11-21

Peptides and methods for the treatment of diabetes

#1469
20190352340
2019-11-21

Peptide compounds to regulate the complement system

#1470
20190352339
2019-11-21

PEPTIDE INHIBITOR OF TRANSMEMBRANE PORE FORMATION AND EFFLUXPUMP FUNCTION IN A SMALL MULTIDRUG RESISTANCE PROTEIN FROM PSEUDOMONAS AERUGINOSA

#1471
20190352338
2019-11-21

INHIBITORS FOR PROTEIN N-TERMINAL METHYLTRANSFERASE AND USES THEREOF

#1472
20190352337
2019-11-21

Antimicrobial peptides with wound healing activity

#1473
20190352335
2019-11-21

BRAIN TARGETING LONG-ACTING PROTEIN CONJUGATE

#1474
20190345201
2019-11-14

Peptide binding to arsenic-containing mineral and use thereof

#1475
20190345200
2019-11-14

Peptide and use thereof

#1476
20190343915
2019-11-14

Laminin receptor peptides for therapy

#1477
20190343914
2019-11-14

Peptidomimetic macrocycles

#1478
20190338050
2019-11-07

PRODUCTION METHOD FOR NONCYCLIC PEPTIDE-NUCLEIC ACID COMPLEX HAVING, AT N-TERMINAL, AMINO ACID WITH THIOL GROUP NEAR AMINO GROUP, LIBRARY THEREOF, AND CYCLIC PEPTIDE-NUCLEIC ACID COMPLEX LIBRARY DERIVED FROM SAME

#1479
20190338000
2019-11-07

Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof

#1480
20190337997
2019-11-07

Modified peptides

#1481
20190337985
2019-11-07

Cell penetrating peptides with improved internalization properties

#1482
20190337984
2019-11-07

Anti-microbial peptides and method for designing novel anti-microbial peptides

#1483
20190337983
2019-11-07

Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

#1484
20190330286
2019-10-31

Immunomodulatory peptide

#1485
20190330275
2019-10-31

NOVEL MUTANT OF a-CONOTOXIN PEPTIDE TxID, PHARMACEUTICAL COMPOSITION AND USE THEREOF

#1486
20190330274
2019-10-31

PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS

#1487
20190330273
2019-10-31

Methods for treating cancer

#1488
20190328910
2019-10-31

Alpha(v)beta(6) integrin-binding peptides and methods of use thereof

#1489
20190328642
2019-10-31

Peptide having skin-whitening activity and use thereof

#1490
20190322720
2019-10-24

Colon and pancreas cancer specific antigens and antibodies

#1491
20190322703
2019-10-24

Immunotherapy against several tumors, such as lung cancer, including NSCLC

#1492
20190322702
2019-10-24

Tricalcium Phosphate Binding Peptides And Uses Thereof

#1493
20190321480
2019-10-24

Compositions and methods for transport across the blood brain barrier

#1494
20190321439
2019-10-24

FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE

#1495
20190321405
2019-10-24

Immunotherapy against neuronal and brain tumors

#1496
20190316163
2019-10-17

METHOD FOR ENHANCING EXTRACELLULAR VESICLE PRODUCTION

#1497
20190316156
2019-10-17

Complexes for gene deletion and editing

#1498
20190315823
2019-10-17

SMALL CATIONIC ANTI-BIOFILM AND IDR PEPTIDES

#1499
20190315805
2019-10-17

TARGETED NONINVASIVE IMAGING PROBES OF EGFR EXPRESSING CELLS

#1500
20190315804
2019-10-17

Peptides capable of reactivating p53 mutants